Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alcohol, typically in the form of an ethanol or isopropyl alcohol-based spray, is a widely used topical antiseptic in clinical settings. In the context of the clinical trial sponsored by Bionorte (NCT02433327), it was utilized as a placebo control to evaluate the efficacy of ethyl chloride vapocoolant spray in reducing procedural pain. The study specifically focused on pain associated with arterial punctures for gasometry determinations in an emergency department. While alcohol is primarily indicated for skin disinfection prior to invasive procedures—acting through the non-specific denaturation of microbial proteins and the dissolution of lipid membranes—it serves as a sensory control in pain studies due to its similar application method and transient cooling sensation upon evaporation, without possessing significant anesthetic properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alcohol.